Steven M. Frisch, Ph.D., Professor in the Biochemistry Department and WVU Cancer Institute at WVU School of Medicine, is the Editor of a new textbook called "Anoikis: How the extracellular matrix regulates life-or-death decisions" (Springer Publications, London).
Dr. Frisch discovered and named Anoikis. Anoikis (pronounced an-oh-EE-kis) is the apoptotic (suicidal) death of cells that are released from their normal attachment sites by the billions per minute. The body depends upon anoikis to prevent the inappropriate re-attachment and growth of these cells, which would promote cancer metastasis.
The book will be available online at Amazon soon.
When you think of ways to treat opioid use disorder, you might think methadone clinics and Narcotics Anonymous meetings. You probably don’t imagine stretches and strengthening exercises. But Anne Swisher—professor at the West Virginia University School of Medicine—is working to address opioid misuse in an unconventional way: through physical therapy. She and her colleagues have enhanced physical therapy instruction at WVU to emphasize the profession’s role in preventing and treating opioid use disorder.
Translating lab discoveries into health care products requires large investments of time and resources.
The WVU Cancer Institute Osborn Hematopoietic Malignancy and Cellular Therapy Program is offering two new forms of chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of lymphoma. These additions double the offerings of the CAR-T therapy line offered by the Institute.